Global Financial Private Client’s Bio-Rad Laboratories Class A BIO Stock Holding History

Global Financial Private Client’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18	Closed	-$4.38K	–	379
2025 Q1	$4.38K	Sell	18 -33	-65%	-$9.93K	﹤0.01%	711
2024 Q4	$16.8K	Sell	51 -37	-42%	-$12.6K	0.01%	456
2024 Q3	$29.4K	Buy	88 +74	+529%	+$23.5K	0.01%	378
2024 Q2	$3.82K	Hold	14	–	–	﹤0.01%	530
2024 Q1	$4.75K	Hold	14	–	–	﹤0.01%	522
2023 Q4	$4.52K	Hold	14	–	–	﹤0.01%	523
2023 Q3	$4.92K	Hold	14	–	–	﹤0.01%	499
2023 Q2	$5.29K	Hold	14	–	–	﹤0.01%	497
2023 Q1	$6.51K	Hold	14	–	–	﹤0.01%	487
2022 Q4	$5.89K	Hold	14	–	–	﹤0.01%	476
2022 Q3	$5.99K	Hold	14	–	–	﹤0.01%	453
2022 Q2	$7.03K	Hold	14	–	–	﹤0.01%	427
2022 Q1	$7.99K	Hold	14	–	–	﹤0.01%	431
2021 Q4	$10.6K	Hold	14	–	–	0.01%	390
2021 Q3	$10.4K	Hold	14	–	–	0.01%	349
2021 Q2	$9.21K	Hold	14	–	–	0.01%	371
2021 Q1	$8.12K	Hold	14	–	–	0.01%	325
2020 Q4	$8.16K	Hold	14	–	–	0.01%	317
2020 Q3	$7.29K	Hold	14	–	–	0.01%	322
2020 Q2	$6.36K	Buy	14 +5	+56%	+$2.21K	0.01%	373
2020 Q1	$3.01K	Hold	9	–	–	﹤0.01%	420
2019 Q4	$3.33K	Buy	+9	New	+$3.17K	﹤0.01%	436

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Global Financial Private Client's BIO Position: Q2 2025 in Review

Global Financial Private Client sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 18 shares — an estimated $4.38K sold.

Global Financial Private Client first reported a position in BIO in Q4 2019 and held it in 22 quarters. The position peaked at $29.4K in Q3 2024. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Global Financial Private Client reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 18 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $4.38K.
Global Financial Private Client first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 22 quarters.
Global Financial Private Client's Bio-Rad Laboratories Class A position peaked at $29.4K in Q3 2024.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.